Mylan, Biocon help market generic insulin drugs





Be worried because they could challenge the patent to the lantus vial but not the pen since the pen is newer than the vial. biologics like lantus are now avaiable to be stolen by generic companies just like lovenox was. lovenox opened the door to this stuff along with our fabulous president. just being honest.